Concepedia

Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure–activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives

Kenji Matsuno, Takashi Seishi, Takao Nakajima, Michio Ichimura, Neill A. Giese, Jin‐Chen Yu, Shoji Oda, Yuji Nomoto

Bioorganic & Medicinal Chemistry Letters · 2003 · 11 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

Todd R. Golub, George F. Barker, Michael Lovett et al. · Cell · 1994 · 1.2K citations

, , +17

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.

Monica Hermanson, Lena Claesson‐Welsh, Carl‐Henrik Heldin et al. · PubMed · 1992 · 701 citations

, , +15

Localization of PDGF-B Protein in Macrophages in All Phases of Atherogenesis

Russell Ross, Junichi Masuda, Elaine W. Raines et al. · Science · 1990 · 584 citations

, , +16

Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization.

J N Wilcox, Kevin M. Smith, L T Williams et al. · Journal of Clinical Investigation · 1988 · 482 citations · Full text

, , +13

Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

Alexander J. Bridges, Hairong Zhou, Donna R. Cody et al. · Journal of Medicinal Chemistry · 1996 · 322 citations · Full text

, , +17